FDA orders tissue-recovery firm to stop manufacturing
This article was originally published in RAJ Devices
The US Food and Drug Administration (FDA) has ordered a US human tissue-recovery firm based in Raleigh, North Carolina and its owner, to stop all manufacturing operations after inspections found serious deficiencies in its manufacturing practices. Donor Referral Services and its owner, Philip Guyett, were also ordered to retain the human cells, tissues and cellular and tissue-based products (HCT/Ps) recovered on or after 25 May 2005 and which were still in the company's possession.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.